Home › Orexo sells Abstral in the United States to Galena Biopharma, Inc.
 

Keywords :   


Orexo sells Abstral in the United States to Galena Biopharma, Inc.

2013-03-18 12:20:48| Biotech - Topix.net

"With an agreement in place for Abstral, we have further strengthened our financial capacity to ensure the optimal launch of Zubsolv in the United States, which will be the primary focus for Orexo in 2013" Orexo AB today announced that it sold AbstralA Sublingual Tablets in the United States to Galena Biopharma, Inc.

Tags: inc united states united states

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
More »